Search

everythinglearnresearchcommunity

for

Search:↓

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

A postmenopausal woman with hair loss and hirsutism improved after surgery to remove an ovarian tumor.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

El Síndrome de Ovario Poliquístico causa problemas de piel como acné y es importante reconocerlo temprano para tratarlo.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Low estrogen compared to androgen may cause female hair loss.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Hyperandrogenism does not affect young women's sexual function.

Estrogen helps promote hair growth in women with androgenetic alopecia.

Hair loss is a common side effect of hormone treatments for cancer.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

COVID-19 vaccines are linked to menstrual changes in many women.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

A postmenopausal woman had rare symptoms due to a possible ovarian tumor, needing thorough evaluation.

Excess maternal androgens can cause heart problems in offspring.